US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AdvisorShares Psychedelics ETF

24.50

-0.6200-2.47%

Post-market: 25.521.02+4.16%17:40 EDT

Volume:57.45K

Turnover:1.40M

Market Cap:56.84M

PE:- -

High:25.32

Open:25.24

Low:24.14

Close:25.12

52wk High:27.02

52wk Low:15.63

Shares:2.32M

Float Shares:2.32M

Volume Ratio:1.27

T/O Rate:2.48%

Dividend:1.70

Dividend Rate:6.95%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

NRx Pharmaceuticals says FDA reclassifies ANDA amendment to ‘minor’

NRX Pharmaceuticals - FDA Revises Gdufa Goal Date for Anda Amendment to November 10, 2026

THOMSON REUTERS

NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine

As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards

Compass Pathways Launches ‘Change the Tune in Trd’ in the U.S. to Advance Hcp Understanding of Treatment-Resistant Depression at Psych Congress 2026

THOMSON REUTERS

Dataworks Group Plans Share and Option Issue to Support Growth

Dataworks launches A$4.24m capital raising to fund growth and strengthen balance sheet

Flynn Gold halts ASX trading ahead of capital raising announcement

Experts Urge FDA to Set Clear Safety and Access Standards for Psychedelic Drugs

NRX Pharmaceuticals Price Target Maintained with a $10.00/Share by BTIG

FDA to Hold Public Hearing on Psychedelic Drugs as Trump-Driven Push Gathers Pace

NRx Pharma Unit GeNeuro Wins European Patent for ALS Antibody Candidate GNK-301

InFocus Group Raises $465,000 to Back New Products and Gaming Tech

Strata Mental Health Solutions awarded training grant by Compass Pathways

Relmada Therapeutics Shares Rise After CEO, CFO Buy 200,000 Shares Each

MT Newswires Live

Dupixent’s Next Move: STYLE 1 Itch Study Wraps Up for Regeneron and Sanofi

NRX Pharmaceuticals' HOPE Therapeutics to Deploy Zeta's TMS Robotic System

MT Newswires Live

Relmada CFO Maged Shenouda Acquires $843,140 of Common Shares

GH Research to Hold One-on-One Investor Meetings at Morgan Stanley Global Healthcare Conference

Evion Moves to Cancel Unpaid Placement Shares and Options

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/PSIL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PSIL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","market":"US","secType":"STK","nameCN":"AdvisorShares Psychedelics ETF","latestPrice":24.5,"timestamp":1789502400000,"preClose":25.12,"halted":0,"volume":57453,"hourTrading":{"tag":"盘后","latestPrice":25.52,"preClose":24.5,"latestTime":"17:40 EDT","volume":114,"amount":2897.920014,"timestamp":1789508452610,"change":1.02,"changeRate":0.041633,"amplitude":0.041633},"delay":0,"changeRate":-0.024681528662420422,"floatShares":2319976,"shares":2319976,"eps":0,"marketStatus":"Post-Mkt","change":-0.62,"latestTime":"09-15 19:22:21 EDT","open":25.24,"high":25.3215,"low":24.14,"amount":1404015.3862019998,"amplitude":0.047034,"askPrice":25.5,"askSize":4,"bidPrice":24.1,"bidSize":10,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":25.12,"sharesOutstanding":1184976,"nav":24.85,"aum":57650992.8,"dividendRate":0.069514,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":25.52,"preClose":24.5,"latestTime":"17:40 EDT","volume":114,"amount":2897.920014,"timestamp":1789508452610,"change":1.02,"changeRate":0.041633,"amplitude":0.041633},"volumeRatio":1.272356,"impliedVol":0.4953,"impliedVolPercentile":0.8446},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSIL\",,,,,undefined,":{"symbol":"PSIL","floatShares":2319976,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.272356,"shares":2319976,"dividePrice":1.7031,"high":25.3215,"amplitude":0.047034,"preClose":25.12,"low":24.14,"week52Low":15.6348,"pbRate":"--","week52High":27.0175,"institutionHeld":0,"latestPrice":24.5,"committee":0.428571,"eps":0,"divideRate":0.069514,"volume":57453,"delay":0,"ttmEps":0,"open":25.24,"prevYearClose":17.17,"prevWeekClose":24.7682,"prevMonthClose":24.62,"prevQuarterClose":24.05,"fiveDayClose":24.96,"twentyDayClose":25.83,"sixtyDayClose":20.0904},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSIL\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PSIL","amount":1.68387,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2025-09-22","symbol":"PSIL","amount":0.02007,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-29","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-29"},{"date":"2025-06-23","symbol":"PSIL","amount":0.01191,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"},{"date":"2025-03-21","symbol":"PSIL","amount":0.16343,"announcedDate":"2025-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-21","defaultRemindTime":1742563800000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-21","currency":"USD","dateTimestamp":1742529600000,"payDate":"2025-03-28"},{"date":"2024-12-23","symbol":"PSIL","amount":0.05477,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"AdvisorShares Psychedelics ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSIL\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-26","recordDate":"2022-09-27","paymentDate":"2022-09-30","value":0.05421,"currency":"USD"},{"executeDate":"2023-09-25","recordDate":"2023-09-26","paymentDate":"2023-09-29","value":0.00336,"currency":"USD"},{"executeDate":"2024-09-23","recordDate":"2024-09-23","paymentDate":"2024-09-30","value":0.1087,"currency":"USD"},{"executeDate":"2024-12-23","recordDate":"2024-12-23","paymentDate":"2024-12-30","value":0.05477,"currency":"USD"},{"executeDate":"2025-03-21","recordDate":"2025-03-21","paymentDate":"2025-03-28","value":0.16343,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSIL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSIL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667621742","title":"NRx Pharmaceuticals says FDA reclassifies ANDA amendment to ‘minor’","url":"https://stock-news.laohu8.com/highlight/detail?id=2667621742","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667621742?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:15","pubTimestamp":1789499711,"startTime":"0","endTime":"0","summary":"NRx Pharmaceuticals (NRXP) announced that it has received a written communication from the Director of Regulatory Operations of the FDA Office of G...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nrx-pharmaceuticals-says-fda-reclassifies-anda-amendment-to-minor-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nrx-pharmaceuticals-says-fda-reclassifies-anda-amendment-to-minor-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NRXP","PSIL","BK4585","BK4588","LABU","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667621265","title":"NRX Pharmaceuticals - FDA Revises Gdufa Goal Date for Anda Amendment to November 10, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667621265","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667621265?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:11","pubTimestamp":1789499515,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nFWN4570DV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","BK4007","NRXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667624858","title":"NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine","url":"https://stock-news.laohu8.com/highlight/detail?id=2667624858","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667624858?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:11","pubTimestamp":1789499460,"startTime":"0","endTime":"0","summary":"Abbreviated New Drug Application (ANDA) Amendment related to the drug vial for preservative-free ketamine has been reclassified from a Major Amendment to a Minor Amendment.FDA has revised the Generic ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/15/3362609/0/en/nrx-pharmaceuticals-nasdaq-nrxp-reports-update-from-the-fda-revising-previous-major-amendment-to-a-minor-amendment-for-preservative-free-ketamine.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","NRXP","LCLG","BK4585","BK4007","LABU","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667862533","title":"As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards","url":"https://stock-news.laohu8.com/highlight/detail?id=2667862533","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667862533?lang=en_us&edition=fundamental","pubTime":"2026-09-15 23:16","pubTimestamp":1789485372,"startTime":"0","endTime":"0","summary":"The strongest evidence for use of the drugs so far has come from trials in patients with severe depression or post-traumatic stress disorder who have not responded to existing treatments.Early-stage trials are also testing psychedelic drugs for substance abuse disorders, borderline personality disorder, obsessive-compulsive disorders, anxiety, self-harm behavior, chronic Lyme disease and fibromyalgia.HOW DO PSYCHEDELIC TREATMENTS WORK?Psychedelic treatments work primarily by activating proteins on the surface of nerve cells that regulate the brain's ability to reorganize, form new connections, and repair damaged circuits. Unlike traditional psychiatric drugs that may be taken at home on a daily basis, these treatments are usually administered by medical personnel in a limited number of sessions to supplement intensive psychotherapy.WHAT PSYCHEDELIC DRUGS ARE CURRENTLY AUTHORIZED FOR USE?In the U.S. and Europe, the leading candidate for authorization is psilocybin, the active ingredient","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL1N4570B8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4533","LU0098860793.USD","BK4568","IE00B19Z3581.USD","LU0345770993.USD","LU2430703095.HKD","LU2133065610.SGD","LU1196500208.SGD","IE000SO60NU8.SGD","IE00BKVL7J92.USD","SGXZ57979304.SGD","LU0545562505.USD","LU2129689605.HKD","IE0009355771.USD","LU1778281490.HKD","LU0289739699.SGD","LU1244550577.SGD","IE000BZT7R73.USD","LU1057294990.SGD","IHE","LU1066053197.SGD","LU2468319806.SGD","LU1496350502.SGD","LU2112291526.USD","IE00B3T34201.USD","BK4139","BK4581","FTXH","LU0795875086.SGD","LU0069063385.USD","LU1244550221.USD","LU1983299246.USD","LU0114720955.EUR","LU1629891620.HKD","LU0058720904.USD","LU1074936037.SGD","LU1506573853.SGD","LU2750360641.GBP","IE000F7OJYX1.SGD","LU0640476718.USD","BK4504","IE000WAW04H5.SGD","LU2456880835.USD","LU0289739343.SGD","LU2592432038.USD","LU0432979614.USD","LU0683600562.USD","IYH","LU0795875169.SGD","LU0964807845.USD","SG9999001176.SGD","TRUH","SG9999001440.SGD","LU1043141396.HKD","IE00B4R5TH58.HKD","LU1551013342.USD","LU1043141123.HKD","IE00BGHQF631.EUR","BK4534","LU1228905540.USD","LU1929549753.HKD","IE00BLSP4239.USD","IE00B3PB1722.GBP","LU0162691827.USD","LU2471134523.USD","LU2896262040.SGD","LU0689626769.HKD","SG9999013999.USD","LU0787776722.HKD","LU0122379950.USD","LU1718418525.SGD","PBM","LU2430703178.SGD","LU2602419157.SGD","LU2471134796.USD","BK4588","IE00BVYPNW00.USD","SG9999001176.USD","LU0820562030.AUD","LU0072461881.USD","LU1261432733.SGD","LU1732799900.SGD","IE00BSNM7G36.USD","BK4559","LU0057025933.USD","LU1989771016.USD","LU1066051225.USD","BK4007","IE00BVYPNV92.GBP","LU0203347892.USD","PJP","IE00BN8TJ469.HKD","LU2756315664.SGD","LU1121112475.USD","LU1267930813.SGD","IE00BFTCPJ56.SGD","LU0320765646.SGD","IE00B2B36J28.USD","LU1894683348.USD","IE00BLSP4452.SGD","LU1244550494.USD","BK4550","LU0203345920.USD","IE00B7SZLL34.SGD","GDOC","LU1894683264.USD","LU0689472784.USD","LU0889566641.SGD","LU2430703251.USD","PSIL","LU1061106388.HKD","LU2505996509.AUD","LU1674673691.USD","LU0943347566.SGD","BK4592","LU1674673428.USD","LU0912757837.SGD","LU0289961442.SGD","IE0000B7K699.USD","LU0792757196.USD","LU1066051811.HKD","LU0234572021.USD","IE0002270589.USD","IE000M9KFDE8.USD","IXJ","RXL","LU2089984988.USD","LU0820561909.HKD","LU0994945656.USD","LU2471134879.HKD","CMPS","LU1551013425.SGD","LU1032955483.USD","LU1585245621.USD","LU1162221912.USD","LU0210536198.USD","LU1430594728.SGD","LU2023250330.USD","LU2347655156.SGD","BMED","LU2213496289.HKD","LU0820561818.USD","LU1291159041.SGD","LU2471134952.CNY","VHT","SG9999002224.SGD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU1221951129.SGD","IE0001KFT4U8.USD","LU2756315318.SGD","LU0472753341.HKD","LU1032466523.USD","LU0426417589.USD","IE00B42XCP33.USD","LU1228905037.USD","IE0034235303.USD","LU0124676726.USD","LU2129689431.USD","LU0511384066.AUD","SG9999002232.USD","LU2750360997.AUD","BK4532","LU1732800096.USD","IE00BDGV0183.EUR","LU0345770308.USD","LU1221951046.USD","IE00BJJMRZ35.SGD","LU1935042991.SGD","FHLC","IE00BBT3K403.USD","LU1145028129.USD","MEDX","IE000MB6IJN5.SGD","IE0002141913.USD","LU0070217475.USD","LU2236285917.USD","LU0882574055.USD","LU1059921491.USD","JDOC","LU1280957306.USD","LU0345769128.USD","LU0210528500.USD","IE00BFXG1179.USD","LU2403377893.USD","LU0426412945.USD","LU1066051498.USD","LU1914381329.SGD","LU2417539215.USD","LU0345769631.USD","IE00BZ1G4Q59.USD","LU0985320562.USD","LU0466842654.USD","LU0053666078.USD","IE00B1BXHZ80.USD","IE00BJT1NW94.SGD","LU2129689514.USD","LU2487616109.SGD","SGXZ80539844.SGD","LU0234570918.USD","JNJ","LU2505996681.GBP","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667462036","title":"Compass Pathways Launches ‘Change the Tune in Trd’ in the U.S. to Advance Hcp Understanding of Treatment-Resistant Depression at Psych Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2667462036","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667462036?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:30","pubTimestamp":1789468200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nTUA90S5ST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","CMPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667200691","title":"Dataworks Group Plans Share and Option Issue to Support Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2667200691","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667200691?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:54","pubTimestamp":1789430077,"startTime":"0","endTime":"0","summary":"IXUP Ltd. ( ($AU:DWG) ) has issued an announcement. Dataworks Group Limited has outlined plans for a new capital raising, proposing the issue of up...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dataworks-group-plans-share-and-option-issue-to-support-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dataworks-group-plans-share-and-option-issue-to-support-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691733","title":"Dataworks launches A$4.24m capital raising to fund growth and strengthen balance sheet","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691733","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691733?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:54","pubTimestamp":1789430069,"startTime":"0","endTime":"0","summary":"IXUP Ltd. ( ($AU:DWG) ) has provided an announcement. Dataworks Group Limited has launched a capital raising of up to A$4.24 million comprising a A...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dataworks-launches-a4-24m-capital-raising-to-fund-growth-and-strengthen-balance-sheet?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dataworks-launches-a4-24m-capital-raising-to-fund-growth-and-strengthen-balance-sheet?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","PSIL","SPHQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667691316","title":"Flynn Gold halts ASX trading ahead of capital raising announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2667691316","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667691316?lang=en_us&edition=fundamental","pubTime":"2026-09-15 07:18","pubTimestamp":1789427896,"startTime":"0","endTime":"0","summary":"Flynn Gold Ltd. ( ($AU:FG1) ) just unveiled an update. Flynn Gold has requested and received a trading halt on its securities on the ASX as it prep...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/flynn-gold-halts-asx-trading-ahead-of-capital-raising-announcement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/flynn-gold-halts-asx-trading-ahead-of-capital-raising-announcement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["159934","PSIL","MGCmain","SGCmain","SGUmain","GLD","GCmain","518880","DUST","IAU","GDX","NUGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667693327","title":"Experts Urge FDA to Set Clear Safety and Access Standards for Psychedelic Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2667693327","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667693327?lang=en_us&edition=fundamental","pubTime":"2026-09-15 03:30","pubTimestamp":1789414223,"startTime":"0","endTime":"0","summary":"UPDATE 2-Experts urge FDA to set clear safety and access standards for psychedelic drugsSept 14 (Reuters)-Doctors, veterans, pharmacists and therapists on Monday urged the U.S. Food and Drug Administr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL1N4560R3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATAI","CMPS","GHRS","BK4007","DFTX","BK4539","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667698261","title":"NRX Pharmaceuticals Price Target Maintained with a $10.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2667698261","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667698261?lang=en_us&edition=fundamental","pubTime":"2026-09-15 02:51","pubTimestamp":1789411860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NRXP/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRXP","BK4007","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667454","title":"FDA to Hold Public Hearing on Psychedelic Drugs as Trump-Driven Push Gathers Pace","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667454","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667454?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:20","pubTimestamp":1789402802,"startTime":"0","endTime":"0","summary":"FDA to hold public hearing on psychedelic drugs as Trump-driven push gathers paceSept 14 (Reuters)-The U.S. Food and Drug Administration will hold a public hearing on Monday to gather feedback on the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nL4N4531CQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","ATAI","GHRS","CMPS","DFTX","PSIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667668873","title":"NRx Pharma Unit GeNeuro Wins European Patent for ALS Antibody Candidate GNK-301","url":"https://stock-news.laohu8.com/highlight/detail?id=2667668873","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667668873?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:04","pubTimestamp":1789383892,"startTime":"0","endTime":"0","summary":"NRx Pharma unit GeNeuro wins European patent for ALS antibody candidate GNK-301NRx Pharmaceuticals’ GeNeuro unit won a European patent covering GNK-301, a monoclonal antibody targeting HERV-K envelope","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL34d93C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","NDAQ","IE00B64PRP62.GBP","BK4588","LU2095319765.USD","BK4007","SG9999014005.SGD","BK4585","LU0314104364.USD","BK4021","IE00BQXX3D17.EUR","LU2210149790.SGD","BK4112","NRXP","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","SG9999014039.USD","IE00BQXX3C00.GBP","LU2210150020.SGD","IE00B3QW5Z07.USD","SG9999014021.USD","PSIL","GNK","IE00BGHQF748.EUR","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BKPKM429.USD","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667655067","title":"InFocus Group Raises $465,000 to Back New Products and Gaming Tech","url":"https://stock-news.laohu8.com/highlight/detail?id=2667655067","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667655067?lang=en_us&edition=fundamental","pubTime":"2026-09-14 15:37","pubTimestamp":1789371472,"startTime":"0","endTime":"0","summary":"The latest update is out from Frugl Group Limited ( ($AU:IFG) ). InFocus Group Holdings Limited has completed a capital raising of $465,000, includ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/infocus-group-raises-465000-to-back-new-products-and-gaming-tech?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/infocus-group-raises-465000-to-back-new-products-and-gaming-tech?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666257102","title":"Strata Mental Health Solutions awarded training grant by Compass Pathways","url":"https://stock-news.laohu8.com/highlight/detail?id=2666257102","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666257102?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:15","pubTimestamp":1789157710,"startTime":"0","endTime":"0","summary":"Strata Mental Health Solutions announced it has been awarded one of the five U.S. HCP training grants awarded by Compass Pathways (CMPS) to develop...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/strata-mental-health-solutions-awarded-training-grant-by-compass-pathways-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/strata-mental-health-solutions-awarded-training-grant-by-compass-pathways-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PSIL","CMPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666311579","title":"Relmada Therapeutics Shares Rise After CEO, CFO Buy 200,000 Shares Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2666311579","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666311579?lang=en_us&edition=fundamental","pubTime":"2026-09-12 02:30","pubTimestamp":1789151447,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics  shares were up nearly 11% in afternoon trading on Friday after the company's Chief Executive Officer Sergio Traversa and Chief Financial Officer Maged Shenouda bought 200,000 shares each, according to separate regulatory filings.Trading volume stood at over 1.7 million shares against a daily average of about 1.8 million.Price: 4.52, Change: +0.44, Percent Change: +10.93","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4007","BK4539","LENZ","PSIL","RLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666057576","title":"Dupixent’s Next Move: STYLE 1 Itch Study Wraps Up for Regeneron and Sanofi","url":"https://stock-news.laohu8.com/highlight/detail?id=2666057576","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666057576?lang=en_us&edition=fundamental","pubTime":"2026-09-12 00:30","pubTimestamp":1789144227,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals ($REGN), Sanofi ($SNYNF) announced an update on their ongoing clinical study. The STYLE 1 study is a Phase 3 trial run by...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dupixents-next-move-style-1-itch-study-wraps-up-for-regeneron-and-sanofi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dupixents-next-move-style-1-itch-study-wraps-up-for-regeneron-and-sanofi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BK4007","SNYNF","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666892521","title":"NRX Pharmaceuticals' HOPE Therapeutics to Deploy Zeta's TMS Robotic System","url":"https://stock-news.laohu8.com/highlight/detail?id=2666892521","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666892521?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:32","pubTimestamp":1789126372,"startTime":"0","endTime":"0","summary":"NRX Pharmaceuticals'  HOPE Therapeutics unit will deploy Zeta Surgical's TMS Robotic System in Florida, with its clinical staff already undergoing orientation and training, NRx said Friday.TMS is a non-invasive therapy mainly used for treatment-resistant depression, and the robotic system's deployment will support NRx's phase 2/3 trial of an NRX-101 combination therapy, the company said.Financial details of the deployment were not disclosed.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NRXP","BK4539","BK4139","BK4007","LENZ","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666529085","title":"Relmada CFO Maged Shenouda Acquires $843,140 of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666529085","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666529085?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:30","pubTimestamp":1789126244,"startTime":"0","endTime":"0","summary":"Relmada CFO Maged Shenouda acquires $843,140 of common sharesRelmada Therapeutics CFO Maged Shenouda bought 200,000 common shares in open-market purchases at about $4.20–$4.25 each.His directly held s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL4WN5mf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Relmada CFO Maged Shenouda Acquires $843,140 of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","BK4007","RLMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666293255","title":"GH Research to Hold One-on-One Investor Meetings at Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666293255","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666293255?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:01","pubTimestamp":1789124491,"startTime":"0","endTime":"0","summary":"GH Research to hold one-on-one investor meetings at Morgan Stanley Global Healthcare ConferenceGH Research will hold one-on-one investor meetings at the Morgan Stanley 24th Annual Global Healthcare Co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL9pJPZ7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2347655156.SGD","BK4007","IE00B775SV38.USD","LU0098860793.USD","LU1244550494.USD","LU1244550577.SGD","LU1732800096.USD","IE00B3S45H60.SGD","LU0314104364.USD","LU1791710400.SGD","LU2023251221.USD","LU2028103732.USD","LU0053666078.USD","BK4504","LU1732799900.SGD","LU0267386448.USD","IAI","LU0882574139.USD","LU0795875086.SGD","LU0390134368.USD","LU1074936037.SGD","LU2264538146.SGD","LU0320765646.SGD","LU0528227936.USD","IE00BKVL7J92.USD","LU1064131342.USD","LU0158827781.USD","LU0234570918.USD","BK4534","LU0557290698.USD","LU1244550221.USD","GHRS","IE00BZ1G4Q59.USD","LU2271345857.HKD","PSIL","BK4516","LU1720051108.HKD","KBWB","LU0225283273.USD","LU1989772923.USD","BK4581","LU0106831901.USD","LU0971096721.USD","LU1989772840.SGD","LU2089283258.USD","LU2357305700.SGD","LU1548497426.USD","BK4127","LU1363072403.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666548670","title":"Evion Moves to Cancel Unpaid Placement Shares and Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2666548670","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666548670?lang=en_us&edition=fundamental","pubTime":"2026-09-11 11:22","pubTimestamp":1789096958,"startTime":"0","endTime":"0","summary":"BlackEarth Minerals NL ( ($AU:EVG) ) has shared an update. Evion Group NL has moved to unwind part of a recent capital raising after certain partic...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evion-moves-to-cancel-unpaid-placement-shares-and-options?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evion-moves-to-cancel-unpaid-placement-shares-and-options?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVG","PSIL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}